Country Profile

Malawi

Malawi is a growing market for Indian pharmaceuticals — $33.4M in FY 2025–26. Medicines accounts for 66% of shipments, with vaccines contributing $10.4M.

🇲🇼 $33.4M · 0.4× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$33.4M
Exports FY2025–26 DGCIS
0.4×
Growth FY2015→2026
66%
Medicines Share
5
Product Categories Supplied
12
Years of Trade Data
Malawi is a growing market for Indian pharmaceuticals — $33.4M in FY 2025–26. Medicines accounts for 66% of shipments, with vaccines contributing $10.4M.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $22.0M (65.8%) Vaccines $10.4M (31.0%) Surgical & Hospital Supplies $492K (1.5%) Medicine Ingredients $456K (1.4%) Traditional & Herbal $111K (0.3%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Malawi in the RBI overseas direct investment dataset (2011–2026).